Dalia Martinez‐Marin

599 citations
17 papers · 478 indexed · h-index 9

Dalia Martinez‐Marin

17 papers receiving 474 citations

Peers

Dalia Martinez‐Marin
Comparison fields: 5 of 79
  • Cancer Research 153
  • Immunology 142
  • Cell Biology 78
  • Molecular Biology 303
  • Immunology and Allergy 23
Replace Jorge Almagro with:
Jorge Almagro United Kingdom
Po-Chien Chou Taiwan
Juan Manuel Iglesias Spain
Hilal Arnouk United States
Javier Mariscal United States
Keli Ma China
Jonathan D. Worboys United Kingdom
Catherine Lee United States
Romain Vauchelles France
Sharon Sanderson United Kingdom
Dalia Martinez‐Marin relative to Jorge Almagro United Kingdom Jorge Almagro's profile →
Citations per field
00.5×
Jorge Almagro · 1×
Citations per year

Countries citing papers authored by Dalia Martinez‐Marin

Since Specialization
Citations

This map shows the geographic impact of Dalia Martinez‐Marin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Martinez‐Marin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Martinez‐Marin more than expected).

Fields of papers citing papers by Dalia Martinez‐Marin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalia Martinez‐Marin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Martinez‐Marin. The network helps show where Dalia Martinez‐Marin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dalia Martinez‐Marin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dalia Martinez‐Marin Line = papers co-authored together Dalia Martinez‐Marin links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20254
2 20242
3 20237
4 20234
5 20238
6 20232
7 20235
8 201813
9 201729
10 201728
11 2017238
12 201712
13 20162
14 20161
15 201422
16 201226
17 201275

About Dalia Martinez‐Marin

Dalia Martinez‐Marin is a scholar working on Transplantation, Immunology and Cancer Research, having authored 17 papers that have together received 478 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), Ubiquitin and proteasome pathways (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Xenotransplantation and immune response (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Cancer Research (153 citations), Immunology (142 citations) and Cell Biology (78 citations). Dalia Martinez‐Marin has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Stéphanie Filleur, Olga V. Volpert, Thomas Nelius, Igal Ifergan, C. Shad Thaxton, Michael P. Plebanek, Yesung Lee, Nicholas L. Angeloni, Reshma Bhowmick and Jack Henkin. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026